Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review
- PMID: 26100618
- DOI: 10.1007/s12016-015-8496-5
Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review
Abstract
Dermatomyositis (DM) is a common idiopathic inflammatory myopathy. The pathogenesis is considered to be microangiopathy affecting skin and muscle. The cutaneous manifestations of DM are the most important aspect of this disease, and their correct evaluation is important for early diagnosis. The skin signs are various: Some are pathognomonic or highly characteristic, and others are compatible with DM. Recently, DM has been categorized into several disease subsets based on the various autoantibodies present in patients. Sometimes, characteristic cutaneous manifestations are strongly associated with the presence of specific autoantibodies. For example, anti-Mi-2 antibody is associated with the classic features of DM, including heliotrope rash, Gottron's papules, the V-neck sign, the shawl sign, cuticular overgrowth, and photosensitivity. Frequent cutaneous features in anti-transcriptional intermediary factor 1 gamma (TIF1γ)-positive patients are diffuse photoerythema, including "dusky red face," while skin ulcerations, palmar papules (inverse Gottron), diffuse hair loss, panniculitis, and oral pain and/or ulcers are sometimes associated with anti-melanoma differentiation-associated gene 5 product (MDA5) antibody. Here, we review important cutaneous manifestations seen in patients with DM, and we examine the relationship between the skin changes and myositis-associated autoantibodies. Correct evaluation of cutaneous manifestations and myositis-associated autoantibodies should help the clinician in the early diagnosis of DM, for a quick recognition of cutaneous signs that may be the symptom of onset before muscle inflammation.
Keywords: Anti-MDA5 antibody; Anti-Mi-2 antibody; Anti-TIF1γ antibody; Cutaneous manifestation; Dermatomyositis; Myositis-associated autoantibody.
Similar articles
-
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.Medicine (Baltimore). 2014 Nov;93(24):318-332. doi: 10.1097/MD.0000000000000222. Medicine (Baltimore). 2014. PMID: 25500701 Free PMC article.
-
Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.Acta Dermatovenerol Croat. 2020 Aug;28(2):120-122. Acta Dermatovenerol Croat. 2020. PMID: 32876041
-
Anti-nuclear matrix protein 2 antibody-positive dermatomyositis associated with smouldering myeloma mimicking anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case of digital gangrene, palmar papules, and scrotal rash.Mod Rheumatol Case Rep. 2025 Jul 25;9(2):rxaf047. doi: 10.1093/mrcr/rxaf047. Mod Rheumatol Case Rep. 2025. PMID: 40679424
-
[Anti-MDA5 dermatomyositis. Literature review].Rev Med Inst Mex Seguro Soc. 2023 Jan 2;61(1):99-105. Rev Med Inst Mex Seguro Soc. 2023. PMID: 36542793 Free PMC article. Review. Spanish.
-
[Myositis and the skin: cutaneous manifestations of dermatomyositis].Brain Nerve. 2013 Nov;65(11):1283-90. Brain Nerve. 2013. PMID: 24200606 Review. Japanese.
Cited by
-
Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib.Intern Med. 2024 Sep 15;63(18):2571-2578. doi: 10.2169/internalmedicine.2915-23. Epub 2024 Feb 12. Intern Med. 2024. PMID: 38346740 Free PMC article.
-
A Case of Paraneoplastic Dermatomyositis Presenting With Malignant Pleural Effusion.Cureus. 2023 May 16;15(5):e39070. doi: 10.7759/cureus.39070. eCollection 2023 May. Cureus. 2023. PMID: 37378107 Free PMC article.
-
A Case in Which Breast Cancer Developed at the Same Time As Dermatomyositis, and the Onset of New Cancer Was Able to Be Predicted by the Exacerbating Skin Symptoms and Parallel Increase in the Anti-TIF1-γ Antibody Levels.Intern Med. 2023;62(20):3057-3062. doi: 10.2169/internalmedicine.0569-22. Epub 2023 Oct 15. Intern Med. 2023. PMID: 37839875 Free PMC article.
-
Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report.JNMA J Nepal Med Assoc. 2025 Jan;63(281):61-64. doi: 10.31729/jnma.8874. Epub 2025 Jan 31. JNMA J Nepal Med Assoc. 2025. PMID: 40655519 Free PMC article.
-
Bullous dermatomyositis with anti-NPX2 antibodies, associated with breast cancer.An Bras Dermatol. 2024 Mar-Apr;99(2):305-307. doi: 10.1016/j.abd.2023.01.007. Epub 2023 Dec 21. An Bras Dermatol. 2024. PMID: 38135558 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources